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Abstract:  The antidiabetic and antilipidemic effects of Bougainvillea glabra was investigated in this study 
using 25 male wistar rats. The rats were divided into 5 groups comprising of five animals each. These groups 
include a normal control (administered saline), an extract control (administered 100 mg/kg of extract) and a 
diabetic control (untreated group). The remaining two groups were administered 100mg/kg and 400 mg/kg of the 
extract respectively. The study lasted for three weeks although blood samples were obtained from the rat tails 
after every week. The results show that the extract significantly (p< 0.05) reduced the hyperglycaemia from 
12±0.40 mmol/L (Diabetic Control) to 4.04±0.03 mmol/L (400 mg/kg group). Likewise, the extract significantly 
reduced  the  Total  Cholesterol  (TC),  Triglyceride  (TG)  and  Low-Density  Lipoprotein  Cholesterol  (LDL-
Cholesterol),  while  increasing  the  High-Density  Lipoprotein  Cholesterol  (HDL-C).  In  conclusion,  the 
observations from this study show that Bougainvillea glabra has antidiabetic effect  and beneficial effects on 
blood lipid profile, thus justifying the use of the plant by traditional medicine practitioners for the treatment of 
diabetes mellitus. 
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1. Introduction 
 
Diabetes mellitus remains a global major health problem in the World over with the tropics 
inclusive. In the past decade, the United States has  recorded a 33% rise in the cases diabetes[1]. 
Despite the significant achievements in treatment modalities and preventive measures, its prevalence 
has risen exponentially in the last decade. Because of these limitations, there is continued need for new 
and more effective therapies  which would improve diabetic control and also reduce associated risk 
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factors like hyperlipidemia, hypertension and so on. A lot of alternative therapies have emerged with 
herbal medicine inclusive. This is why the use of herbs has more than tripled over the last 10 years [2]. 
  Herbal therapies such as the Konjac-Mann [3], honey [4,5]. Azadirachta indica [6], Glucolevel 
(a combination of four anti-diabetic plants used in the traditional Arab herbal medicine) [7] have all 
shown ameliorating effects in the control of hyperglycemia in Diabetes Mellitus. 
  Bougainvillea (with the common name Glory of the Garden), originated from South America 
and it is a popular plant in Southern California, Florida, the Caribbean and other areas with tropical 
and warm climates [8]. It is a thorny woody plant with flowers ranging from pink, purple, red, orange, 
yellow  colours  and  especially  white  [9,10].  Among  the  Bougainvillea’s  varieties  include 
Bougainvillea glabra, Bougainvillea spectabilis, and Bougainvillea harrisi. Bougainvillea glabra is 
grown for its decorative purposes in tropical regions and in the temperate [8]. In some areas like the 
Western Europe, North Africa, Middle East and the Indian Sub-continent, B. Spectabilis, is used to 
shorten the life span of sand flies that cause leishmaniasis [11].  Bougainvillea spectabilis is also used 
in  herbal  combination for  the  treatment  of  diabetes  [12].  Information  also  exist  about  the  use  of 
Bougainvillea  glabra  in  the  cure  of  ulcer,  diarrhoea,  and  having  anti-microbial  activities[13]. 
Information  from  some  traditional  medical  practitioners  show  that  some  beetles  that  feed  on  any 
Bougainvillea stems are dried, crushed into powder and added as main ingredient in popular herbal 
combinations used in the treatment of diabetes mellitus. These herbal formulations are said to be 
incomplete without the Bougainvillea stem beetle-fed ground powder[14]. 
  This  study  was  designed  to  examine  the  hypoglycemic  and  antilipidemic  effects  of 
Bougainvillea  glabra  another  Bougainvillea  species  apart  from  B.  spectabilis  on  alloxan-induced 
Diabetes Mellitus based on the local uses of the plant for the treatment of diabetes mellitus. 
 
 
2. Materials and Methods 
 
2.1. Plant Material  
 
Bougainvillea glabra leaves were collected from the University of Ilorin Botanical Garden. 
The leaves were removed from the stalk and air dried at room temperature (22 ± 1 
0C) after which it 
was  ground  and  sieved  to  fine  powder  and  made  into  extracts  used  for  the  experiment.  The 
phytochemical analyses were carried out using the method of Trease and Evans [15].  
 
2.2  Animals   
 
Twenty-five  matured  male  albino  rats  weighing  between  150-200  g  were  used  for  the 
experiment.  Rats  were  housed  with  ad  libitum  access  to  water  in  a  well-  ventilated  animal  unit 
provided by the Department of Physiology, University of Ilorin (21 ± 5
0C, humidity 60 %, 12h light/ 
dark cycle). The rats were fed standard chow (Bendel Feed Ltd, Ilorin). 
 
2.3 Experimental Design 
The  experiment  lasted  for  21  days.  The  experimental  animals  were  allowed  2-week 
acclimatization  to  laboratory  environment  and  they  were  subsequently  divided  into  five  groups 
comprising of 5 rats each. The animal groupings are as follows:  
A-Normal Control: given standard rat chow and 10mL/kg of distilled,  
B-  Normal  animals administered Bougainvillea  glabra  extract (100  mg/kg)  along  side  the 
standard rat chow,  
C-  Diabetic  rat  administered  alloxan  according  to  the  standard  procedure  [16],  those  that 
developed diabetes were afterwards given the standard rat chow for 21 days,  
D-The animals were made diabetic and administered the plant extract (100 mg/kg) 
E- The animals were made diabetic and administered the plant extract (400 mg/kg) 
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  Alloxan (Sigma Aldrich, St Quentin- Fallvier, France) was injected through the penial vein at 
a dose of 65 mg alloxan/ kg [17]  after a 24-hour fast, and confirmation of an elevated blood sugar was 
done 3 days later. 
 
2.4 Biochemical Analysis 
 
 Plasma Glucose Test:  Blood was collected from the tail of the rats. The blood sugar was 
estimated using the PRESTIGE SMART SYSTEM
TM, Home Diagnostics, Inc. Ft Lauderate, USA) 
Glucometer. The glucose estimation was made weekly throughout the study. 
 
Lipid Profile: Blood for the determination of lipid profile was collected from the tail of the 
rats and measurements were carried out using an Automated Analyzer (Roche, HITACHI). 
 
2.5 Statistical Analysis 
 
Values were recorded as Mean ± standard error of the mean. Statistical difference between the 
means was determined by ANOVA followed by  Duncan post Hoc test. P< 0.05 was accepted as 
significance level.  
 
3.  Results and Discussion   
  The  phytochemical  analysis  of  the  extract  reveals  the  presence  of  alkaloids,  flavonoids, 
saponins and cardiac glycosides in Bougainvillea glabra, as shown in Table 1. The results of the anti-
diabetic test shows that the 100 mg/kg extract of Bougainvillea glabra significantly (p<0.05) reduced 
the blood glucose level in the diabetic animals induced with alloxan. The 400mg/kg extract group also 
reduced the blood glucose level significantly (p<0.05). The reduction of the diabetes in the alloxan- 
induced animals (Group C) by the extract groups (D and E) was compared with the normal control and 
non- diabetic extract fed groups (A and B) respectively. It was observed that the Groups A, B, D and E 
had significantly reduced levels of glucose, unlike the increased glucose levels seen in the alloxan-
induced animals (Group C) as shown in Table 2. The results of the lipid profile showed that the 100 
mg/kg extract group of Bougainvillea glabra significantly (p<0.05) reduced the TG, LDL-C and TC, 
compared with the alloxan-induced diabetic group (Group C). The HDL-C which was reduced in the 
diabetic animals was increased in the groups administered the Bougainvillea glabra extract. This was 
also observed in the 400 mg/kg extract group. The normal control and non-diabetic-extract fed groups 
also had a significantly high HDL-C while the TC, TG and LDL-C were significantly reduced as 
shown as Figure 1. 
  A major serum abnormality in Diabetes Mellitus is hyperglycemia, which was induced in the 
diabetic  rats  in  the  present  study.  This  is  as  a  result  of  the  pancreatic  β  cell  destruction  with 
intravenous  injection  of  alloxan  [16].  The  Bougainvillea  glabra  aqueous  leaf  extract  significantly 
reduced (P<0.05) the hyperglycemic effect of the alloxan induced diabetes in the groups treated with 
Bougainvillea  glabra  extract.  This  agrees  with  the  local  uses  of  the  leaves  of  the  plant  for  the 
treatment of diabetes by traditional medicine practitioners [12]. 
  We also reported the beneficial effect of HDL-C that is referred to as the ‘good’ cholesterol, 
which  was  increased  in  the  diabetic  groups  administered  the  Bougainvillea  glabra  extract.  Major 
complications  of  Diabetes  include  aberrant  lipid  metabolism  and  vascular  wall  function.  Since 
alterations  in  serum  lipid  profiles  are  known  in  diabetes  which  are  likely  to  increase  the  risk  of 
coronary heart disease, a reduction in serum lipids, particularly TC, LDL-C and TG levels should be 
considered as beneficial in long-term prognosis of diabetic patients. Bougainvillea glabra extract will 
thus have a potential therapeutic value in combating multifactorial atherosclerotic disorders, which are 
parts of the major complications of Diabetes. Reducing the risk of atherosclerosis will thus lead to the 
development of effective and better management of hyperlipidemia. Aqueous extract of Bougainvillea glabra  
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Bougainvillea  glabra  like  its  other  species  Bougainvillea  spectabilis  may  contain  D-pinitol  (3-O-
methylchiroinositol) compound, which could explain its insulin-like effects. A number of plants with 
potent therapeutic components like fibers, sterols, saponins, polyphenols, flavonoids etc have been 
investigated for their antihyperlipidemic, antioxidant and antiatheroscelorotic properties [18]. These 
components- alkaloids, flavonoids, saponins and cardiac glycosides were present in the Bougainvillea 
glabra  plant  extract.  Since  their  potent  properties  can  ameliorate  the  risk  factors  associated  with 
Diabetic  Mellitus,  they  can  be  said  to  curb the  effects  of  Diabetes.  These  compounds  have  been 
reported to be beneficial with great variation in magnitude and mechanism of action [19, 20]. 
In  conclusion,  the  present  study  has  shown  that  the  aqueous  extract  of  the  leaves  of 
Bougainvillea glabra has anti-diabetic and anti-lipidemic effects. These observations also justify the 
traditional uses of the plant leaves for the treatment of diabetes. 
 
                Table 1.  Phytochemicals Analysis of Aqueous extract of B. glabra leaves 
Phytochemical Analysis  Presence 
Alkaloids  + 
Flavonoids  + 
Cardiac glycosides  + 
Saponins  + 
   
               + indicate the presence of active compounds in the extract of Bougainvillea glabra. 
Table 2.  Weekly changes in the glucose level (mmol/L) of the rats following the administration of 
saline, normal diet and aqueous extract of B. glabra. 
    Groups  PreTest 
Week 1  Week 2  Week 3 
A  5.5±0.39  5.75±0.20  5.90±0.23  5.90±0.23 
B  5.45±0.40  5.25±0.25  5.25±0.25  5.60±0.25 
C  12.10±0.40  12.10±0.40  12.02±0.40  12.05±0.50 
D  12.10±0.40  6.23±0.41  5.04±0.03  3.24±0.28* 
E  12.10±0.40  5.23±0.50  4.74±0.41  4.04±0.03* 
         
All values are mean ±S.E.M, n(no of rats per group)= 5 (A-Normal, B-Normal animals fed extract, C-Diabetic 
untreated rats, D-Diabetic rats fed 100mg/kg of extract, E-Diabetic rats fed 400mg/kg of extract), (p< 0.05). 
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Figure 1. Plasma lipid profile in control and alloxan-induced diabetic rats and after treatment with 
Bougainvillea glabra 
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